Eucalyptus — Antimicrobial & Wound Care

Eucalyptus branch with sickle-shaped blue-green leaves
Eucalyptus globulus, the blue gum whose leaf oil has been tested against many bacteria in the laboratory.
Infographic: eucalyptus oil entering a bacterial membrane and breaking up a biofilm
In laboratory studies eucalyptus oil compounds such as cineole enter bacterial membranes and disrupt biofilm signals; these are test-tube findings, not wound trials.
Dark red kino resin oozing from eucalyptus bark
Kino, the dark red astringent gum-resin from eucalyptus bark, applied to cuts, burns and sores in Australian Aboriginal tradition.

Long before modern microbiology gave us a name for Staphylococcus aureus or methicillin-resistant Staphylococcus aureus (MRSA), Australian Aboriginal peoples were applying the sticky red kino resin from eucalyptus trees to cuts, burns, and sores — an effective wound antiseptic with tens of thousands of years of empirical use. Modern in-vitro work has demonstrated broad-spectrum antibacterial activity for Eucalyptus globulus essential oil against both Gram-positive and Gram-negative pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) at minimum inhibitory concentrations of 0.125–1.0% v/v, plus key respiratory pathogens (Haemophilus influenzae, Haemophilus parainfluenzae, Streptococcus pneumoniae) and oral biofilm organisms (Streptococcus mutans, Porphyromonas gingivalis, Fusobacterium nucleatum). The antimicrobial mechanism is multi-target — cineole, alpha-pinene, limonene, p-cymene, and globulol all integrate into bacterial cell membranes, disrupting the proton motive force and quorum-sensing biofilm signals — which is why bacteria struggle to develop resistance to essential oils the way they do to single-compound antibiotics. This page walks through the in-vitro evidence, the dental and oral applications (eucalyptol is an active ingredient of essential-oil mouthwashes), the Aboriginal kino tradition, the surgical antiseptic history dating to Joseph Lister, and the modern wound-dressing research.


Table of Contents

  1. Australian Aboriginal Kino Tradition
  2. Multi-Target Antibacterial Mechanism
  3. Methicillin-Resistant Staphylococcus Aureus and Antibiotic-Resistant Pathogens
  4. Activity Across Gram-Positive and Gram-Negative
  5. Biofilm and Quorum-Sensing Disruption
  6. Oral and Dental Antimicrobial Use (Essential-Oil Mouthwash)
  7. Wound Care and Topical Antiseptic
  8. Lister and the Surgical Antiseptic Era
  9. Synergy with Conventional Antibiotics
  10. Preparations and Topical Dilution
  11. Cautions
  12. Key Research Papers
  13. Connections
  14. Featured Videos

Australian Aboriginal Kino Tradition

The earliest documented medicinal use of eucalyptus is in Australian Aboriginal pharmacopoeia, where the genus has played a central role for tens of thousands of years — predating any written medical tradition by a wide margin. The signature preparation is kino, the dark red, astringent gum-resin that exudes from wounds in the bark of certain eucalyptus species (particularly Eucalyptus citriodora, E. resinifera, and E. camaldulensis). Kino is rich in polyphenolic tannins, kinotannic acid, and pyrocatechin — compounds that astringe tissues, precipitate bacterial surface proteins, and form a temporary protective barrier over wounds.

Aboriginal healers applied freshly harvested kino directly to cuts, burns, abscesses, ulcers, sores, and the umbilical stumps of newborns. The astringent precipitation of mucus and surface protein creates a localized antimicrobial environment, and the tannins themselves have direct bacteriostatic activity against many skin and wound pathogens. Aboriginal women across many Australian language groups also chewed kino for sore throats and chewed eucalyptus leaves for the same purpose, recognizing the same active properties that we now call essential-oil terpenoids.

Eucalyptus leaves themselves were processed in several ways: chewed for mouth and throat infections, made into infusions for fevers and respiratory congestion, pounded into pastes and applied to wounds, and burned in smoking ceremonies that simultaneously purified living spaces of biting insects and respiratory pathogens. The smoke ceremonies were sometimes carried out at the entrance to dwellings during epidemic illness.

The pharmacological sophistication is striking. Aboriginal communities distinguished among the hundreds of Eucalyptus species and selected specific ones for specific purposes — species rich in kino resin for wound work, species rich in volatile oil for respiratory steam ceremonies, and species with particular taste and bitterness for digestive complaints. This was not random foraging; it was a knowledge system passed orally across generations that mapped chemotype to clinical effect long before any chemist isolated a single terpene.

Back to Table of Contents

Multi-Target Antibacterial Mechanism

The antibacterial potency of Eucalyptus globulus essential oil derives from a complex terpenoid mixture, with each component contributing through distinct biochemical mechanisms. Unlike single-target pharmaceutical antibiotics — penicillin binds penicillin-binding proteins; ciprofloxacin inhibits DNA gyrase — eucalyptus attacks bacterial cells on several fronts at once.

The mechanistic upshot: bacteria exposed to eucalyptus essential oil suffer simultaneous membrane permeabilization, leakage of ions and small molecules, collapse of the transmembrane proton gradient (which powers adenosine triphosphate (ATP) synthesis and most active transport), and disruption of membrane-anchored signaling proteins. Electron microscopy of eucalyptus-treated bacteria shows visible morphological damage: membrane blebbing, cytoplasmic condensation, and at higher doses complete cell lysis.

Because each component compound hits a slightly different molecular target, evolving resistance requires simultaneous mutations in multiple bacterial systems — statistically vanishingly unlikely on the timescales over which antibiotic resistance normally develops. This is the same logic behind combination antiretroviral therapy for human immunodeficiency virus (HIV): three drugs hitting three different targets defeat any single-mutation escape.

Back to Table of Contents

Methicillin-Resistant Staphylococcus Aureus and Antibiotic-Resistant Pathogens

The single most striking finding in modern eucalyptus antimicrobial research is its retained activity against methicillin-resistant Staphylococcus aureus (MRSA). Methicillin-resistant Staphylococcus aureus is defined by resistance to the beta-lactam antibiotic class (penicillins, cephalosporins, carbapenems) via the mecA-encoded modified penicillin-binding protein PBP2a. Because eucalyptus oil does not act on penicillin-binding proteins at all — it disrupts the membrane upstream of any wall-synthesis machinery — the resistance mechanism is completely irrelevant to its activity.

Reported minimum inhibitory concentration (MIC) values for E. globulus oil against methicillin-resistant Staphylococcus aureus clinical isolates fall in the 0.125–1.0% (v/v) range, depending on the specific oil chemotype, the methicillin-resistant Staphylococcus aureus strain, and the assay method. Minimum bactericidal concentration (MBC) is typically within one to two dilutions of minimum inhibitory concentration, indicating rapid killing rather than mere growth arrest. These concentrations are easily achievable in topical formulations. In a direct laboratory comparison (Hendry 2009), however, chlorhexidine, the standard hospital antiseptic, was significantly more active than eucalyptus oil against microbes both free-floating and grown in biofilms.

Eucalyptus oil retains activity against other resistant pathogens of clinical importance:

The clinical translation is not that essential oils replace intravenous (IV) vancomycin for systemic methicillin-resistant Staphylococcus aureus bacteremia — they cannot achieve therapeutic plasma levels and are not formulated for parenteral use. The translation is that for topical and surface applications — wound care, skin colonization eradication, hospital surface disinfection, dental biofilm management — eucalyptus oil is a viable adjunct that does not select for the same resistance phenotypes as conventional antibiotic agents.

A 2023 systematic review (Elangovan and Mudgil) gathered 20 studies published between 2002 and 2022 that tested Eucalyptus globulus essential oil against methicillin-resistant Staphylococcus aureus, alone or combined with other agents. The studies found antibacterial activity against it, and found that the effect could be stronger when the oil was combined with other essential oils or with antibiotics. All of this work was done in the laboratory; the review included no clinical trials in people.

For more on staphylococcal infection, see our Staphylococcus aureus page.

Back to Table of Contents

Activity Across Gram-Positive and Gram-Negative

Gram-positive bacteria (single thick peptidoglycan cell wall, single plasma membrane) are generally more susceptible to essential oils than Gram-negative bacteria (additional outer membrane with lipopolysaccharide barrier). Eucalyptus oil follows that general pattern but retains useful activity across both groups.

Gram-positive susceptibility (typical MICs 0.125–1% v/v):

Gram-negative susceptibility (typical MICs 1–5% v/v):

For more on respiratory bacterial infection, see our Pneumonia page; for urinary infection, see Urinary Tract Infections.

Back to Table of Contents

Biofilm and Quorum-Sensing Disruption

The greatest clinical advantage of eucalyptus oil over many conventional antibiotics is its activity against bacterial biofilms. Biofilms are structured communities of bacteria embedded in a self-produced extracellular matrix of polysaccharides, proteins, and DNA. Biofilm-embedded bacteria are 100 to 1,000 times more resistant to conventional antibiotics than the same species in planktonic (free-floating) form. Many chronic infections — chronic sinusitis, otitis media with effusion, chronic prostatitis, diabetic foot ulcers, venous leg ulcers, indwelling-catheter colonization, prosthetic-joint infection — are biofilm-driven and notoriously resistant to systemic antibiotic therapy.

Eucalyptus oil disrupts biofilms through two distinct mechanisms:

The dental application is the most evidence-supported real-world example: dental plaque is a polymicrobial biofilm, and the essential-oil mouthwashes (the best known combines eucalyptol with thymol, menthol, and methyl salicylate) demonstrably reduce plaque mass, gingival inflammation, and total oral bacterial counts compared to control rinses. The mechanism is the same biofilm-matrix-penetration logic operating on a smaller scale.

The chronic-wound application is less clinically developed but actively studied. In-vitro work has shown eucalyptus oil penetrates and disrupts S. aureus and P. aeruginosa biofilm cultures grown on wound-relevant substrates. Clinical case series have reported improved healing outcomes when eucalyptus-based dressings are part of a comprehensive wound-care protocol, though high-quality randomized controlled trials remain limited.

Back to Table of Contents

Oral and Dental Antimicrobial Use (Essential-Oil Mouthwash)

The most universally familiar antimicrobial application of eucalyptol is the mouthwash. Eucalyptol is one of the four active essential-oil compounds in the best-known essential-oil mouthwash, alongside thymol (from thyme), menthol (from mint), and methyl salicylate. Together these four actives at concentrations of approximately 0.092% (eucalyptol), 0.064% (thymol), 0.042% (menthol), and 0.060% (methyl salicylate) produce the characteristic flavor and the documented oral-antimicrobial effect of that mouthwash and its generic equivalents.

Controlled trials comparing essential-oil mouthwash with control rinses have shown:

Comparison to chlorhexidine, the prescription gold-standard mouthwash, is the more interesting trial design. Chlorhexidine is more potent on a per-rinse basis for short-term plaque suppression, but it has two real-world disadvantages that eucalyptol-containing mouthwashes do not share: it causes brown tooth staining with chronic use, and it produces a temporary taste disturbance that many patients find intolerable. The 2007 review above found that most studies agreed the essential-oil rinse caused no more staining than the control products.

Specific oral pathogens hit by eucalyptol:

The volatile-sulfur-compound producers (P. gingivalis, P. intermedia, T. denticola) are the primary contributors to halitosis, and reduction in their populations explains why essential-oil mouthwash produces sustained breath improvement beyond the immediate masking effect of the menthol.

Back to Table of Contents

Wound Care and Topical Antiseptic

Topical eucalyptus oil at appropriate dilution has documented antibacterial activity against wound-relevant pathogens (S. aureus, P. aeruginosa, Acinetobacter baumannii) and combined antibacterial-plus-anti-inflammatory effects that distinguish it from purely antiseptic agents.

Burns. Burn wounds are highly susceptible to bacterial colonization, particularly by S. aureus, P. aeruginosa, and A. baumannii. Animal burn-wound model studies have shown that topical eucalyptus oil at 2–5% dilution in a carrier reduces wound bacterial counts by 2–3 log units versus untreated controls and promotes faster epithelialization. The anti-inflammatory action reduces excessive inflammation in the burn bed, which can impede healing.

Chronic ulcers. Diabetic foot ulcers and venous leg ulcers represent a major clinical challenge due to persistent bacterial biofilm infection. The biofilm-disrupting properties of eucalyptus oil discussed above are particularly relevant. Eucalyptus has been formulated into hydrogels, nanofiber mats, chitosan films, and alginate dressings for sustained-release antibacterial delivery; in-vitro testing of these advanced dressings has shown inhibition of wound-relevant pathogen growth alongside maintained cytocompatibility with human fibroblasts and keratinocytes.

Insect bites and minor wounds. Diluted eucalyptus oil applied topically to insect bites provides both antibacterial protection against secondary infection and a local cooling-analgesic effect via TRPM8 activation (covered on the Pain & Joint Relief page). Aboriginal traditional use of kino on cuts and abrasions falls into the same category.

Dilution. Undiluted eucalyptus essential oil is too irritating for direct application to a wound; the dilutions described for wound-area use are 1–2% in a carrier oil (jojoba, coconut, sweet almond), or a commercial preparation already formulated for topical use. Substantial burns, deep wounds, and chronic ulcers are beyond what home topical care covers; spreading redness, fever, or pus around a wound are signs of a spreading infection.

Back to Table of Contents

Lister and the Surgical Antiseptic Era

Joseph Lister's 1867 introduction of antiseptic surgery using carbolic acid (phenol) is widely credited as the foundation of modern surgical practice — the breakthrough that turned operating theaters from charnel-house mortality factories into the survivable-procedure environments we expect today. What is less remembered is that eucalyptus oil rapidly joined carbolic acid as an alternative surgical antiseptic, particularly across the British Empire's tropical and Antipodean territories.

The Melbourne chemist (pharmacist) Joseph Bosisto, founder of the Pharmaceutical Society of Victoria in 1857, arrived in Melbourne in 1851 and, with help from the government botanist Ferdinand von Mueller, set up his first still for commercial distillation of eucalyptus oil at Dandenong (Victoria), supplying medical-grade product to military and civilian hospitals across Australia and from there to Britain. By the 1880s, eucalyptus oil appeared in the British Pharmacopoeia and was listed in multiple colonial pharmacopoeias as an approved wound antiseptic. Australian military surgeons used eucalyptus-based antiseptic preparations extensively during the Boer War and World War I, with favorable wound-healing outcomes reported in dispatches.

Eucalyptus oil's advantage over carbolic acid was twofold: significantly less tissue toxicity at antimicrobial concentrations, and a more tolerable scent for both patient and surgical staff. Carbolic acid at the concentrations needed for reliable antisepsis caused chemical burns, cleaved skin proteins, and was systemically toxic if absorbed. Eucalyptus oil, while not bacteria-killing on the same per-volume basis as carbolic acid, produced sufficient bactericidal effect at concentrations the surrounding tissues tolerated well.

The eucalyptus-as-surgical-antiseptic era waned with the introduction of synthetic antiseptics (hexachlorophene, povidone-iodine, chlorhexidine) in the mid-20th century, which were standardizable to a precision impossible with natural essential oils. But the historical reputation cemented eucalyptus oil's position in the hospital pharmacy and in over-the-counter (OTC) topical preparations through to the present day.

Back to Table of Contents

Synergy with Conventional Antibiotics

One of the most clinically promising areas of current eucalyptus research is the demonstration of synergistic interaction with conventional antibiotic drugs. Synergism — defined as a combined effect exceeding the sum of individual effects — allows lower doses of each agent to achieve equivalent or superior antibacterial activity. This is measured by the fractional inhibitory concentration index (FICI); FICI values below 0.5 indicate true synergism.

The one checkerboard study of eucalyptus-oil compounds cited on this page (Mulyaningsih 2010, on oil from eucalyptus fruits) found that combining aromadendrene with 1,8-cineole lowered the minimum inhibitory concentrations “in most cases in an additive way”, while time-kill tests suggested a synergistic effect. The fruit oil inhibited methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis. All of this is laboratory work.

Combinations reported in laboratory research include (the ampicillin, gentamicin, ciprofloxacin, tea tree and thyme combinations below are not tested in any of the papers listed on this page):

These synergistic combinations are an active area of research, with potential to restore the clinical effectiveness of older antibiotics against resistant pathogens. Sub-inhibitory concentrations of eucalyptus oil — below the level that would itself kill bacteria — appear to be enough to disable resistance mechanisms and resensitize bacteria to standard antibiotic therapy.

Back to Table of Contents

Preparations and Topical Dilution

Topical dilutions commonly described:

Commercial preparations:

Back to Table of Contents

Cautions

Back to Table of Contents

Key Research Papers

  1. Mulyaningsih S, Sporer F, Zimmermann S, Reichling J, Wink M (2010). Synergistic properties of the terpenoids aromadendrene and 1,8-cineole from the essential oil of Eucalyptus globulus against antibiotic-susceptible and antibiotic-resistant pathogens. Phytomedicine 17(13):1061–1066 (oil from the fruits; aromadendrene-rich). — PubMed PMID: 20727725
  2. Hendry ER, Worthington T, Conway BR, Lambert PA (2009). Antimicrobial efficacy of eucalyptus oil and 1,8-cineole alone and in combination with chlorhexidine digluconate against microorganisms grown in planktonic and biofilm cultures. Journal of Antimicrobial Chemotherapy 64(6):1219–1225. — PubMed PMID: 19837714
  3. Bachir RG, Benali M (2012). Antibacterial activity of the essential oils from the leaves of Eucalyptus globulus against Escherichia coli and Staphylococcus aureus. Asian Pacific Journal of Tropical Biomedicine 2(9):739–742. — PubMed PMID: 23570005
  4. Cermelli C, Fabio A, Fabio G, Quaglio P (2008). Effect of eucalyptus essential oil on respiratory bacteria and viruses. Current Microbiology 56(1):89–92. — PubMed PMID: 17972131
  5. Elaissi A, Rouis Z, Salem NAB, Mabrouk S, Salem YB, Salah KBH, Aouni M, Farhat F, Chemli R, Harzallah-Skhiri F, Khouja ML (2012). Chemical composition of 8 eucalyptus species' essential oils and the evaluation of their antibacterial, antifungal and antiviral activities. BMC Complementary and Alternative Medicine 12:81. — PubMed PMID: 22742534
  6. Tyagi AK, Malik A (2011). Antimicrobial potential and chemical composition of Eucalyptus globulus oil in liquid and vapour phase against food spoilage microorganisms. Food Chemistry 126(1):228–235. — doi:10.1016/j.foodchem.2010.11.002
  7. Stoeken JE, Paraskevas S, van der Weijden GA (2007). The long-term effect of a mouthrinse containing essential oils on dental plaque and gingivitis: a systematic review. Journal of Periodontology 78(7):1218–1228. — PubMed PMID: 17608576
  8. DePaola LG, Overholser CD, Meiller TF, Minah GE, Niehaus C (1989). Chemotherapeutic inhibition of supragingival dental plaque and gingivitis development (essential-oil mouthwash). Journal of Clinical Periodontology 16(5):311–315. — PubMed PMID: 2723103
  9. Sherry E, Boeck H, Warnke PH (2001). Topical application of a new formulation of eucalyptus oil phytochemical clears methicillin-resistant Staphylococcus aureus infection. American Journal of Infection Control 29(5):346 (a one-paragraph letter). — PubMed PMID: 11584265
  10. Salari MH, Amine G, Shirazi MH, Hafezi R, Mohammadypour M (2006). Antibacterial effects of Eucalyptus globulus leaf extract on pathogenic bacteria isolated from specimens of patients with respiratory tract disorders. Clinical Microbiology and Infection 12(2):194–196. — PubMed PMID: 16441463
  11. Elangovan S, Mudgil P (2023). Antibacterial properties of Eucalyptus globulus essential oil against MRSA: a systematic review. Antibiotics (Basel) 12(3):474. — PubMed PMID: 36978341
  12. Tibballs J (1995). Clinical effects and management of eucalyptus oil ingestion in infants and young children. Medical Journal of Australia 163(4):177–180. — PubMed PMID: 7651249
  13. Day LM, Ozanne-Smith J, Parsons BJ, Dobbin M, Tibballs J (1997). Eucalyptus oil poisoning among young children: mechanisms of access and the potential for prevention. Australian and New Zealand Journal of Public Health 21(3):297–302. — PubMed PMID: 9270157
  14. Dudipala SC, Mandapuram P, Ch LK (2021). Eucalyptus oil-induced seizures in children: case reports and review of the literature. Journal of Neurosciences in Rural Practice 12(1):112–115. — PubMed PMID: 33531768
  15. Suresh D, VijayaKumar S, Pradhan P, Balasubramanian S (2025). Fatal eucalyptus oil poisoning in an adult male: a case report with comprehensive autopsy and histopathological findings. Cureus 17(4):e83053. — PubMed PMID: 40432665

PubMed Topic Searches

  1. PubMed: Eucalyptus and MRSA
  2. PubMed: Biofilm disruption
  3. PubMed: Essential-oil mouthwash trials
  4. PubMed: Wound antiseptic use
  5. PubMed: Aboriginal kino tradition

Back to Table of Contents

Connections

Back to Table of Contents